Literature DB >> 27055387

Interventional oncology for hepatocellular carcinoma.

Julien Delicque1, Mathieu Boulin2, Boris Guiu3, Jean-Pierre Pelage1, Laure Escal1, Valentina Schembri1, Eric Assenat4, Audrey Fohlen5.   

Abstract

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is increasing in incidence. The overall prognosis of patients with liver cancer is poor. The Barcelona Clinic Liver Cancer (BCLC) classification in 5 stages is endorsed by European Association for the Study of the Liver (EASL) and American Association for the Study of Liver Disease (AASLD). This classification is recommended for treatment allocation. Because a small proportion of patients are suitable for curative surgical treatment, various locoregional therapies are widely used to manage patients with HCC. The image-guided therapies, also called interventional radiology or interventional oncology (IO) techniques consisted in percutaneous or endovascular approach. This article reviews the different IO treatments available in HCC patients and the strength of the data.
Copyright © 2016. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Year:  2016        PMID: 27055387     DOI: 10.1016/j.clinre.2016.01.007

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  3 in total

Review 1.  Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.

Authors:  Konstantinos Katsanos; Panagiotis Kitrou; Stavros Spiliopoulos; Ioannis Maroulis; Theodore Petsas; Dimitris Karnabatidis
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

2.  S100 family members: potential therapeutic target in patients with hepatocellular carcinoma: A STROBE study.

Authors:  Cai Zhang; Rucheng Yao; Jie Chen; Qiong Zou; Linghai Zeng
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

3.  A Novel Multi-Mode Thermal Therapy for Colorectal Cancer Liver Metastasis: A Pilot Study.

Authors:  Wentao Li; Yue Lou; Guangzhi Wang; Kangwei Zhang; Lichao Xu; Ping Liu; Lisa X Xu
Journal:  Biomedicines       Date:  2022-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.